Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL-108 for pain and OINV after third molar extraction
NCT01780428Phase 3Completed
- Sponsor
- Charleston Laboratories, Inc.
- Start
- Jan 2013
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydrocodone + acetaminophen + promethazine in pain, nausea ((none)) and Vomiting (3 arms), sponsored by Charleston Laboratories, Inc. Primary endpoints: Opioid-Induced Nausea and Vomiting at 24 hours and Summed Pain Intensity Difference over 24 hours. Started Jan 2013; status: completed.
02
Drugs
hydrocodone + acetaminophen + promethazine
03
Conditions
painnausea ((none))Vomiting
Beyond the preview
Go deeper on NCT01780428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780428.